Superbioavailable Itraconazole 130mg versus Itraconazole 200mg in extensive dermatophytosis.
Phase 4
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2024/08/072159
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of age above 18 years having extensive dermatophytosis (Body surface area involvement more than 10 percentage)
Exclusion Criteria
Patient on topical antifungal therapy (15 days before study). Pregnancy.
Patient having Tinea unguium, Tinea capitis infection. Patient living with HIV, diabetes mellitus.
Patients on systemic immunosuppressive therapy. Patients missing follow up for more than a month. Patients not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method